ASN
RLAY icon

Advisory Services Network’s Relay Therapeutics RLAY Stock Holding History

Advisory Services Network’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,697
Closed -$16.9K – 4112
2026
Q1 		$16.9K Buy
+1,697
New +$15.2K ﹤0.01% 3289
2025
Q4 		– Sell
-81
Closed -$423 – 3741
2025
Q3 		$423 Buy
+81
New +$309 ﹤0.01% 4077

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Advisory Services Network's RLAY Position: Q2 2026 in Review

Advisory Services Network sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 1,697 shares — an estimated $16.9K sold.

Advisory Services Network first reported a position in RLAY in Q3 2025 and held it in 2 quarters. The position peaked at $16.9K in Q1 2026. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Advisory Services Network reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 1,697 Relay Therapeutics shares in Q2 2026, an estimated $16.9K.
  • Advisory Services Network first reported a position in Relay Therapeutics in Q3 2025 and held it in 2 quarters.
  • Advisory Services Network's Relay Therapeutics position peaked at $16.9K in Q1 2026.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.